Secondary hormonal therapies in the treatment of prostate cancer
Data up to Jan 2025
Total Citations Per Year
Abstract
References (33)
Cancer Statistics, 2001
2001 • 3,342 citations
Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.
1996 • 1,584 citations
Hydrocortisone With or Without Mitoxantrone in Men With Hormone-Refractory Prostate Cancer: Results of the Cancer and Leukemia Group B 9182 Study
1999 • 907 citations
Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist.
1999 • 592 citations
Treatment of metastatic prostatic cancer with low-dose prednisone: evaluation of pain and quality of life as pragmatic indices of response.
1989 • 417 citations
Prostate Specific Antigen Decline after Antiandrogen Withdrawal: the Flutamide Withdrawal Syndrome
1993 • 354 citations
Clinical and Biologic Activity of an Estrogenic Herbal Combination (PC-SPES) in Prostate Cancer
1998 • 297 citations
MANAGEMENT OF HORMONE REFRACTORY PROSTATE CANCER: CURRENT STANDARDS AND FUTURE PROSPECTS
1998 • 266 citations
Bicalutamide for advanced prostate cancer: the natural versus treated history of disease.
1997 • 231 citations
Functional characterization of mutant androgen receptors from androgen-independent prostate cancer.
1997 • 225 citations
Second-line hormonal therapy for advanced prostate cancer: a shifting paradigm.
1997 • 215 citations
HIGH DOSE BICALUTAMIDE FOR ANDROGEN INDEPENDENT PROSTATE CANCER: EFFECT OF PRIOR HORMONAL THERAPY
1998 • 210 citations
Ketoconazole Retains Activity in Advanced Prostate Cancer Patients with Progression Despite Flutamide Withdrawal
1997 • 200 citations
Induction of Apoptosis by Diethylstilbestrol in Hormone-Insensitive Prostate Cancer Cells
1996 • 190 citations
Prospective Trial of the Herbal Supplement PC-SPES in Patients With Progressive Prostate Cancer
2000 • 185 citations
A phase II trial of oral diethylstilbesterol as a second-line hormonal agent in advanced prostate cancer
1998 • 181 citations
Prostate-specific antigen decline after casodex withdrawal: Evidence for an antiandrogen withdrawal syndrome
1994 • 174 citations
Low doses of oral dexamethasone for hormone-refractory prostate carcinoma
2000 • 127 citations
Dramatic Prostate Specific Antigen Decrease in Response to Discontinuation of Megestrol Acetate in Advanced Prostate Cancer: Expansion of the Antiandrogen Withdrawal Syndrome
1995 • 124 citations
Phase II trial of bicalutamide in patients with advanced prostate cancer in whom conventional hormonal therapy failed: a Southwest Oncology Group study (SWOG 9235)
2001 • 101 citations
PC‐SPES, a dietary supplement for the treatment of hormone‐refractory prostate cancer
2000 • 94 citations
A randomized study comparing standard versus moderately high dose megestrol acetate for patients with advanced prostate carcinoma
2000 • 85 citations
PC-SPES: A unique inhibitor of proliferation of prostate cancer cells in vitro and in vivo
2000 • 84 citations
Activity of the herbal combination, PC-SPES, in the treatment of patients with androgen-independent prostate cancer
2001 • 76 citations
HERBAL THERAPY PC-SPES: IN VITRO EFFECTS AND EVALUATION OF ITS EFFICACY IN 69 PATIENTS WITH PROSTATE CANCER
2000 • 71 citations
HERBAL THERAPY PC-SPES: IN VITRO EFFECTS AND EVALUATION OF ITS EFFICACY IN 69 PATIENTS WITH PROSTATE CANCER
2000 • 66 citations
Randomized phase 2 trial of ketoconazole and ketoconazole/doxorubicin in androgen independent prostate cancer
2001 • 61 citations
Ketoconazole: A Possible Direct Cytotoxic Effect on Prostate Carcinoma Cells
1989 • 61 citations
Treatment of progressive metastatic prostate cancer.
1993 • 58 citations
Low-dose continuous oral fosfestrol is highly active in 'hormone-refractory' prostate cancer
2000 • 45 citations
SECONDARY HORMONAL MANIPULATIONS IN HORMONE REFRACTORY PROSTATE CANCER
1999 • 31 citations
Almost split sequences in categories of representations of quivers
2000 • 13 citations
PC-SPES: Current Evidence and Remaining Questions
2001 • 10 citations